The NST is a simple pen and paper questionnaire, which is based on 10 individual items representing common areas of parent reported behavioural concerns in children with FASD. It
is intended to be used as a brief screening instrument as part of a diagnostic interview conducted by a psychologist, in a variety of settings. Scores from the NST are able to statistically differentiate children with a suspected FASD from typically developing children, children with ADHD, and children with ODD/CD. The presentation will focus on NST research to date, as well describe
how the tool may be used in a clinical setting through a case vignette.


Join us For a Webinar on April 19, 1:00 – 2:30 pm EDT

Reserve your Webinar seat now at:


Presenter Bios:

Dr. Gideon Koren is the founder and director of the Motherisk
Program and a professor of Pediatrics, pharmacology, pharmacy and medicine. He
is a staff pediatrician at The Hospital for Sick Children in Toronto and the
author/co-author of hundreds of scientific articles, book chapters and
abstracts. He is a member of numerous professional societies. In 1999 he
received the Irving Sunshine Award (awarded by the International Association of
Therapeutic Drug Monitoring & Clinical Toxicology), and in 1997 he received
the prestigious Rawls-Palmer Award. Both awards were for outstanding
contributions to clinical toxicology. In March 2000 Dr. Koren received the
Medical Research Council of Canada’s Senior Scientist award for his work in
Population Health Sciences, and in September 2003 he was awarded the Pippenger
Award for outstanding achievement by the International Association for
Therapeutic Drug Monitoring and Clinical Toxicology. Dr. Koren is founder of
the FACE (Fetal Alcohol Canadian Expertise) Network and the peer reviewed
Journal of FAS International. In 2004 Dr. Koren was appointed as the Ivey Chair
in Molecular Toxicology at the University of Western Ontario. He is creating a
Canadian Network of Human Toxicology.

Carmen Rasmussen, PhD in Developmental Psychology, is an
Assistant Professor in the Department of Pediatrics at the University of
Alberta and a Research Affiliate at the Glenrose Rehabilitation Hospital, in
Edmonton, Alberta. She researches neurobehavioral functioning in children with

Dr. Kelly Nash is currently working as a psychologist in
supervised practice at McMaster Children’s Hospital, in the Child and Youth
Mental Health Outpatient Program. Alongside her clinical practice, Dr. Nash
continues her research into understanding the neurobehavioural phenotype in children
with Fetal Alcohol Spectrum Disorders (FASD), with a particular interest in
improving and developing diagnostic and intervention strategies. Her doctoral
research focused on evaluating the behavioural and neuroplastic outcomes
following self-regulation therapy for children with FASD.

Click here for article